Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Howard Pringle

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Histopathology|September 2, 2011
Prognostic tissue markers in melanomaDavid A Moore, J Howard Pringle, Gerald S Saldanha
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequenciesGerald Saldanha, Linda Potter, Philip Daforno, et al.
Anticancer Research|January 30, 2003
Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotidesAnthony H Taylor, Farook al-Azzawi, J Howard Pringle, et al.
International Journal of Cancer|July 15, 2004
High BRAF mutation frequency does not characterize all melanocytic tumor typesGerald Saldanha, David Purnell, Alan Fletcher, et al.
Cancer Research|May 31, 2002
Changes in tenascin-C isoform expression in invasive and preinvasive breast diseaseMatthew Adams, J Louise Jones, Rosemary A Walker, et al.
Cancer Metastasis Reviews|September 4, 2010
Expression of tenascin-C and its isoforms in the breastDavid S Guttery, Jacqueline A Shaw, Kirsty Lloyd, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
microRNA-10b is a prognostic biomarker for melanomaGerald Saldanha, Shona Elshaw, Parysatis Sachs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 8, 2016
5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanomaGerald Saldanha, Kushal Joshi, Kathryn Lawes, et al.
The Journal of Molecular Diagnostics : JMD|July 2, 2013
Accurate detection of copy number changes in DNA extracted from formalin-fixed, paraffin-embedded melanoma tissue using duplex ratio testsDavid A Moore, Gerald Saldanha, Abdlrzag Ehdode, et al.
Journal of Molecular Neuroscience : MN|June 10, 2003
Nuclear immunostaining in rat neuronal cells using two anti-Kir2.2 ion channel polyclonal antibodiesAnthony H Stonehouse, Blair D Grubb, J Howard Pringle, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Histopathology|September 2, 2011
Prognostic tissue markers in melanomaDavid A Moore, J Howard Pringle, Gerald S Saldanha
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequenciesGerald Saldanha, Linda Potter, Philip Daforno, et al.
Anticancer Research|January 30, 2003
Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotidesAnthony H Taylor, Farook al-Azzawi, J Howard Pringle, et al.
International Journal of Cancer|July 15, 2004
High BRAF mutation frequency does not characterize all melanocytic tumor typesGerald Saldanha, David Purnell, Alan Fletcher, et al.
Cancer Research|May 31, 2002
Changes in tenascin-C isoform expression in invasive and preinvasive breast diseaseMatthew Adams, J Louise Jones, Rosemary A Walker, et al.
Cancer Metastasis Reviews|September 4, 2010
Expression of tenascin-C and its isoforms in the breastDavid S Guttery, Jacqueline A Shaw, Kirsty Lloyd, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
microRNA-10b is a prognostic biomarker for melanomaGerald Saldanha, Shona Elshaw, Parysatis Sachs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 8, 2016
5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanomaGerald Saldanha, Kushal Joshi, Kathryn Lawes, et al.
The Journal of Molecular Diagnostics : JMD|July 2, 2013
Accurate detection of copy number changes in DNA extracted from formalin-fixed, paraffin-embedded melanoma tissue using duplex ratio testsDavid A Moore, Gerald Saldanha, Abdlrzag Ehdode, et al.
Journal of Molecular Neuroscience : MN|June 10, 2003
Nuclear immunostaining in rat neuronal cells using two anti-Kir2.2 ion channel polyclonal antibodiesAnthony H Stonehouse, Blair D Grubb, J Howard Pringle, et al.
Pageof 3